Now playing Next Europe News Three key moments from the first debate with lead EU candidates The lead candidates in the European elections faced off against each other in the first debate of the race, haggling over the Green Deal, the Israel-Hamas war, irregular migration, artificial intelligence and TikTok, among others. 29/04/2024
Now playing Next Health news EU Policy. Commission approves superbug-busting antibiotic The European Commission today (22 April) authorised a new antibiotic designed to counter anti-bacterial resistance, one of the biggest health threats the EU is currently facing. 22/04/2024
Now playing Next Health news What is Pregabalin and why is it causing concern in the UK? The anti-anxiety drug has been linked to fatalities in the UK, leading people taking the drug to come forward about their debilitating side effects. 07/03/2024
Now playing Next Health news Officials look into rare disorder in older adults who got RSV vaccine Officials are investigating a rare nervous system disorder in older adults who received the RSV vaccine. 01/03/2024
Now playing Next Health news Why is €2 billion worth of COVID drug Paxlovid going to waste? European countries rushed to buy the antiviral drug in January 2022, but now it’s going to waste. Why? 24/02/2024
Now playing Next Markets Novo Nordisk crossroads: Can the pharma giant address the supply woes? Novo Nordisk faces a pivotal moment as it grapples with supply issues amid soaring demand for its weight-loss drugs. Despite impressive financial gains and market dominance, the Danish pharma giant must navigate a critical decision. 10/02/2024
Now playing Next Health news COVID vaccine may have short-term impact on menstrual cycles - study A French study found an increased but short-term risk of changes to women's menstrual cycles after they received the COVID-19 mRNA vaccine. 01/02/2024
Now playing Next Culture news What is Biden’s ‘Taylor Swift Plan’ – and why is MAGA on the warpath? President Joe Biden is reportedly seeking TayTay’s endorsement once more in order to swing this year’s US presidential election – something which has led to some outrageous conspiracy theories. Here’s the breakdown. 31/01/2024
Now playing Next Business Have healthcare stocks been under the weather in 2023? Euronews Business looks at how major healthcare stocks such as Pfizer and Moderna performed this year 29/12/2023
Now playing Next Business Why has Italy abandoned the New Silk Road project with China? Italy exits the New Silk Road: Euronews Business explores what this agreement encompasses and which countries are still involved. 07/12/2023
Now playing Next Business Denmark's Novo Nordisk invests €2.1 billion in France Danish pharmaceutical giant Novo Nordisk has announced major investment in a French production site to expand the capacity and manufacturing of its blockbuster anti-obesity drug. 24/11/2023
Now playing Next Business Biden-Xi meeting: These are the biggest takeaways The leaders of the world's largest economies left with friendly words and a set of agreements after their highly anticipated meeting. 16/11/2023
Now playing Next Health news Calls for more testing amid rising infant syphilis cases in the US The CDC said "increasing rates of syphilis among babies reflect a failure of the US health system". 08/11/2023
Now playing Next Business How are businesses responding to the Israel Hamas war? As the death toll from Israel’s offensive in Gaza rises, corporate communications are in crisis mode. 01/11/2023
Now playing Next Business Kellogg’s split: A common business strategy? American company Kellogg’s split up into two separate companies earlier in October. Demergers constitute a rather common business strategy. 07/10/2023
Now playing Next Health news From mRNA to attoseconds: The discoveries behind the 2023 Nobel prizes The scientific discoveries behind the 2023 Nobel Prizes in Medicine, Physics and Chemistry are impacting how we live our lives. 04/10/2023
Now playing Next Health news COVID: Should we fear a new winter wave? Since mid-July, Europe has been experiencing a resurgence in cases of COVID due in part to the emergence of new variants. 11/09/2023
